KR100877189B1 - Process for Making Functional Foods Containing Dietary Fiber and Functional Foods Thereof - Google Patents
Process for Making Functional Foods Containing Dietary Fiber and Functional Foods Thereof Download PDFInfo
- Publication number
- KR100877189B1 KR100877189B1 KR1020070053866A KR20070053866A KR100877189B1 KR 100877189 B1 KR100877189 B1 KR 100877189B1 KR 1020070053866 A KR1020070053866 A KR 1020070053866A KR 20070053866 A KR20070053866 A KR 20070053866A KR 100877189 B1 KR100877189 B1 KR 100877189B1
- Authority
- KR
- South Korea
- Prior art keywords
- dietary fiber
- powder
- bifidus
- chocolate
- intake
- Prior art date
Links
- 235000013325 dietary fiber Nutrition 0.000 title claims abstract description 97
- 238000000034 method Methods 0.000 title claims abstract description 5
- 235000013376 functional food Nutrition 0.000 title claims description 27
- 230000008569 process Effects 0.000 title description 2
- 239000000843 powder Substances 0.000 claims abstract description 84
- 235000019219 chocolate Nutrition 0.000 claims abstract description 72
- 241000894006 Bacteria Species 0.000 claims abstract description 39
- 238000004519 manufacturing process Methods 0.000 claims abstract description 26
- 239000000758 substrate Substances 0.000 claims abstract description 17
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 16
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 14
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 14
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 11
- 238000004806 packaging method and process Methods 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 230000000968 intestinal effect Effects 0.000 abstract description 13
- 235000000346 sugar Nutrition 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000004913 activation Effects 0.000 abstract description 6
- 238000002156 mixing Methods 0.000 abstract description 4
- 230000000737 periodic effect Effects 0.000 abstract description 3
- 239000002417 nutraceutical Substances 0.000 abstract 1
- 235000021436 nutraceutical agent Nutrition 0.000 abstract 1
- 244000299461 Theobroma cacao Species 0.000 description 67
- 235000013305 food Nutrition 0.000 description 20
- 235000013361 beverage Nutrition 0.000 description 12
- 230000006870 function Effects 0.000 description 10
- 235000005911 diet Nutrition 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 235000013339 cereals Nutrition 0.000 description 7
- 230000037406 food intake Effects 0.000 description 7
- 229920001542 oligosaccharide Polymers 0.000 description 7
- 150000002482 oligosaccharides Chemical class 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 239000003925 fat Chemical group 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- 239000011247 coating layer Substances 0.000 description 4
- 235000019868 cocoa butter Nutrition 0.000 description 4
- 229940110456 cocoa butter Drugs 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 150000002772 monosaccharides Chemical class 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000002641 glycemic effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000001046 cacaotero Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 102000038379 digestive enzymes Human genes 0.000 description 2
- 108091007734 digestive enzymes Proteins 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000008944 intestinal immunity Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 239000011707 mineral Chemical group 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000009967 tasteless effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000032754 Infant Death Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000000837 carbohydrate group Chemical group 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- -1 lactose carbohydrates Chemical class 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 235000000112 undernutrition Nutrition 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Chemical group 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Chemical group 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical group 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명에서는 식이섬유의 지속적이고 주기적인 섭취를 위하여 분말화된 난소화성 말토덱스트린이 초콜릿에 첨가되며, 또한 이러한 난소화성 말토덱스트린이 장내 비피더스를 활성화시킴에 따라, 기재로서의 초콜릿에 비피더스를 첨가하여 비피더스의 장내 활성화를 더욱 향상시키고, 아울러, 초콜릿에 의해 우려될 수 있는 혈당의 상승은 상기 난소화성 말토덱스트린에 의해 조절시켜 그 구성성분이 서로 조화되도록 하며 섭취가 용이한 식이섬유가 함유된 기능성 식품제조방법 및 기능성식품이 제공된다.In the present invention, powdered indigestible maltodextrin is added to chocolate for continuous and periodic intake of dietary fiber, and as such indigestible maltodextrin activates intestinal bifidus, bifidus is added to chocolate as a substrate by adding bifidus. Increasing the intestinal activation of blood sugar, and the increase in blood sugar that may be a concern with chocolate is controlled by the indigestible maltodextrin to ensure that its components are in harmony with each other and contains easy-to-eat dietary fiber Methods and nutraceuticals are provided.
이를 위한 본 발명은 섭취가능한 식이섬유로서 난 소화성 말토덱스트린 분말을 제조하는 식이섬유분말 제조단계와; 상기 식이섬유분말 제조와 별도로 섭취를 위한 분말로서 비피더스균 분말 제조단계와; 상기 식이섬유분말과 상기 비피더스균 분말을 바인딩하며, 상기 획득된 식이섬유 분말과 비피더스 분말을 섭취하기 용이한 기호품으로 형성하기 위하여 초콜릿과 혼합하는 바인딩단계 및 ; 상기 식이섬유분말과 비피더스균 분말이 첨가된 초콜릿을 포장하는 포장단계로 이루어진다.To this end, the present invention provides a dietary fiber powder manufacturing step of preparing an indigestible maltodextrin powder as an ingestible dietary fiber; A step of preparing bifidobacteria powder as a powder for intake separate from the preparation of the dietary fiber powder; A binding step of binding the dietary fiber powder and the bifidus powder and mixing with the chocolate to form the obtained dietary fiber powder and the bifidus powder into a preferred product easily ingested; The dietary fiber powder and bifidus bacteria powder is added to the packaging step of packaging.
이때, 상기 식이섬유분말은 총중량에 대해 6중량% 내지 30중량%로 첨가되며, 상기 비피더스균분말은 총중량에 대해 0.5중량% 내지 3중량%로 첨가되어 이루어진다.At this time, the dietary fiber powder is added in 6% by weight to 30% by weight relative to the total weight, the bifidus powder is made by adding 0.5% to 3% by weight relative to the total weight.
Description
도 1 은 본 발명의 제조방법을 나타낸 개념도이다.1 is a conceptual diagram showing a manufacturing method of the present invention.
본 발명은 식이섬유로서 난소화성 말토덱스트린이 함유된 기능성 식품에 관한 것으로, 구체적으로는 식이섬유의 지속적이고 주기적인 섭취를 위하여 분말화된 난소화성 말토덱스트린이 초콜릿에 첨가되며, 또한 이러한 난소화성 말토덱스트린이 장내 비피더스를 활성화시킴에 따라, 기재로서의 초콜릿에 비피더스를 첨가하여 비피더스의 장내 활성화를 더욱 향상시키고, 아울러, 초콜릿에 의해 우려될 수 있는 혈당의 상승은 상기 난소화성 말토덱스트린에 의해 조절시켜 그 구성성분이 서로 조화되도록 하며 섭취가 용이한 식이섬유가 함유된 기능성 식품제조방법 및 기능성식품에 관한 것이다.The present invention relates to a functional food containing an indigestible maltodextrin as a dietary fiber, specifically a powdered indigestible maltodextrin is added to chocolate for continuous and periodic intake of the dietary fiber, and also such an indigestible maltodextrin. As dextrin activates intestinal bifidus, bifidus is added to chocolate as a substrate to further enhance intestinal activation of bifidus, and the increase in blood glucose that may be caused by chocolate is controlled by the indigestible maltodextrin The present invention relates to a functional food manufacturing method and a functional food containing dietary fiber that allow the ingredients to harmonize with each other.
일반적으로 사람의 의식주 생활에서 건강을 위하여 식생활이 중요한 위치를 차지하며, 이것은 인체가 항상성을 유지하면서 정상적인 생리기능을 원활히 수행하기 위하여 섭취하는 영양소들의 대부분을 음식물의 형태로 섭취하고 있기 때문이라 할 것이다.In general, the diet occupies an important position for health in human consciousness life, because the human body ingests most of the nutrients ingested in the form of food to maintain normal homeostasis and perform normal physiological functions smoothly. .
즉, 인체에 필요한 40 여종의 영양소는 식품을 통해 이루어지고 개인의 식품기호는 식품의 선택에 영향을 미치게 되며, 잘못된 식생활은 영양부족, 과잉영양 및 잘못된 영양정보에 의한 영양불량을 초래하기 쉽다.That is, about 40 kinds of nutrients necessary for the human body are made through food, and individual food symbols affect food selection, and wrong eating is likely to cause malnutrition due to undernourishment, overnutrition and wrong nutritional information.
바람직하기로는 하루에 5가지 기초 식품군인 단백질군, 칼슘군, 무기질 및 비타민군, 탄수화물군, 지방군을 골고루 섭취하여야 하며, 특히 식이섬유를 충분하게 섭취하고 식염을 줄이고 과도한 단백질 섭취를 방지하여야 한다.Preferably, five basic food groups, protein group, calcium group, mineral and vitamin group, carbohydrate group, and fat group should be ingested every day, and in particular, the dietary fiber should be sufficiently ingested, reduced salt and prevent excessive protein intake.
그러나, 현대의 식생활은 이를 충족시키지 못함이 일반적이고 예를 들어, 음식물 섭취가 어느 한 종류로 편중되어 어느 요소는 부족하고 어느 요소는 과잉되는 현상을 초래하여, 영양불균형과 과잉섭취로 인한 체중과다 및 비만은 오늘날 보건문제로 대두되고 있을 뿐만 아니라, 동맥경화증, 당뇨병, 고혈압과 같은 만성 퇴행성 질환의 발병을 더욱 가중시키게 된다.However, modern diets generally do not meet this, and for example, food intake is one-sided, which results in the lack of one element and the excess of one, resulting in overweight due to malnutrition and excess intake. And obesity are not only emerging as a health problem today, but they further increase the development of chronic degenerative diseases such as atherosclerosis, diabetes and hypertension.
따라서, 건강과 질병에 미치는 상기 음식물의 잠재적 역할에 관계되어, 필요한 요소를 섭취하기 위한 경로로서 다양한 건강보조식품이 안출되어 있다.Therefore, in relation to the potential role of the food on health and disease, various dietary supplements have been devised as a route for ingesting necessary elements.
이러한 식품의 주원료 성분들은 저마다 독특한 약리작용을 가지고 있으며, 주원료 성분들이 중첩될 수도 있다.Each of the main ingredients of the food has a unique pharmacological action, the main ingredients may overlap.
이러한 주원료의 컴비네이션은 어떠한 요소를 채택시키느냐에 따라 시너지 작용을 발생시키며, 수많은 주원료가 산재됨을 감안할 때 그 컴비네이션은 다수의 경우의 수를 가지게 된다.Such a combination of main raw materials generates synergy depending on which element is adopted, and the combination has a number of cases in consideration of the scattering of a large number of main raw materials.
따라서, 이러한 산재된 식품의 주요소에서 어떠한 것들을 조합시키야 하는 가, 그리고 특히 섭취의 용이성을 향상시키기 위한 가공된 기능성 식품으로서 어떠한 기재로 섭취보조를 위한 기호품을 채택할 것인가가 주요한 관건이라 할 수 있으며, 이러한 조건에서 특유의 기능을 갖는 건강보조식품의 개발은 상당한 어려움이 뒤따르게 되는 것이다.Therefore, the main issue is what should be combined in the main components of these interspersed foods, and in particular what kind of substrate to adopt as a functional functional food to improve the ease of ingestion, the choice of supplementary supplements for intake, Under these conditions, the development of dietary supplements with specific functions is accompanied by significant difficulties.
본 발명은 상기 거론된 바람직한 식생활을 위하여 요구되는 식이섬유와 이것의 충분한 섭취를 위한 기능성식품에 관계된다.The present invention relates to the dietary fiber required for the preferred diet discussed above and to a functional food for its sufficient intake.
상기 식이섬유는 비영양성 다당류로서 소화효소로 소화되지 않는 물질이다. 그러나, 식이섬유가 배변량을 늘려주고 변의 장내 체류시간을 단축시켜 주는 등 대장 기능에 변화를 가져오며, 장질환과 관상질환에 대해 예방 및 치료효과와, 식이섬유의 섭취가 혈청 콜레스테롤 양을 감소시켜주고 혈압을 저하키고 있음이 증명되었다. The fiber is a non-nutritive polysaccharide that is not digested with digestive enzymes. However, dietary fiber changes the bowel function by increasing the amount of bowel movement and shortening the intestinal dwelling time, and preventing and treating the bowel disease and coronary disease, and the intake of dietary fiber reduces the amount of serum cholesterol It has been proven to lower blood pressure.
또한, 식이섬유의 섭취는 심혈관계 질환의 예방과 치료에 도움을 줄 뿐 아니라 당뇨병, 비만해소, 변비완화 및 소화관 기능개선, 몇 종류 암의 발병율 저하 등 현대생활에서 나타나기 쉬운 만성질병에 도움을 줌으로서, 최근 만성질환의 예방과 처치에 있어서 식이요법으로서 중요하게 부각되고 있다.In addition, intake of dietary fiber not only helps prevent and treat cardiovascular diseases, but also helps chronic diseases that are likely to occur in modern life, such as diabetes, obesity, constipation and improved digestive tract function, and the incidence of several types of cancer. In recent years, as a dietary therapy in the prevention and treatment of chronic diseases has emerged as important.
이것은 특히, 식이섬유의 글리세믹스인덱스(GI)에 관계되며, 글리세믹스인덱스란 글루코스 50g을 섭취한 경우의 혈당곡선하면적을 산출하여 그 수치를 100으로 하였을 때와 동량의 탄수화물을 함유한 식품을 섭취했을 때의 혈당치곡선하면적과 비교하여 수치화한 것을 의미한다.This is especially related to the glycemic index (GI) of dietary fiber, Calcium Glycemic index is calculated by calculating the area of the blood sugar curve when ingesting 50g of glucose, and consumed food containing the same amount of carbohydrates When the blood sugar level curve when compared to the mean value is compared.
낮은 GI식 식생활이란, 혈당치의 급격한 상승을 억제하고 인슐린의 과다 분 비를 억제하며, 체지방의 과잉된 축적을 억제하여 컨트롤하기 위한 것으로, 식이섬유의 섭취시 이것은 대장까지 분포되어 혈당치가 급격히 상승하는 것을 방지하고 비교적 장시간에 걸쳐 서서히 혈당이 상승하도록 유도시킨다.Low GI diet is to suppress the rapid rise in blood sugar levels, to suppress the excessive secretion of insulin, and to control by inhibiting the excessive accumulation of body fat, which is distributed to the large intestine when the intake of dietary fiber, the blood sugar level rises rapidly Prevents blood sugar from rising slowly over a relatively long period of time.
이것은 예를 들어 식이섬유로서 난 소화성 말토덱스트린은 탄수화물과 함께 섭취되었을 때, 탄수화물의 분해효소인 아밀라아제가 난 소화성 말토덱스트린에 흡착되고 탄수화물(다당류)이 단당류로 분해되는 것이 방해되어 체내의 혈당이 급격히 상승하는 것이 방지되기 때문이다.This means that, for example, when digestive maltodextrins, which are dietary fiber, are ingested with carbohydrates, the amylose, a carbohydrate degrading enzyme, is absorbed by the digestive maltodextrins and the carbohydrates (polysaccharides) are broken down into monosaccharides, causing blood glucose to rapidly break down. This is because rising is prevented.
이러한 이유에서 상기 거론된 식생활에서 식이섬유의 충분한 섭취는 중요한 위치를 차지하며, 이것이 부족하게 되는 경우 식후 혈당치의 급격한 상승은 인슐린의 과분비를 불러오고, 고지혈증이나 체지방의 축적은 당뇨병이나 고혈압 동맥경화를 불러일으키게 되는 것이다.For this reason, sufficient intake of dietary fiber occupies an important position in the above-mentioned diet, and when this is insufficient, a rapid increase in postprandial blood glucose levels leads to hypersecretion of insulin, and hyperlipidemia or body fat accumulation leads to diabetes or hypertension arteriosclerosis. It is aroused.
한편, 상기 식이섬유의 또 다른 기능으로는 장내환경을 개선하는 비피더스균의 활성화에 있다. 비피더스균은 이것이 생산하는 항생물과 유기산이 유해균을 억제시켜 독소를 생성하고 설사를 유발하는 유해균을 억제시키는 작용을 수행한다.On the other hand, another function of the dietary fiber is the activation of bifidus bacteria to improve the intestinal environment. Bifidobacteria acts to inhibit harmful bacteria that produce antitoxins and diarrhea by inhibiting harmful bacteria and organic acids produced by them.
이러한 이유에서 비피더스균에 의한 면역은 아토피 치료에 효과가 있는 것으로 알려지고 있으며, 비피더스균이 장의 연동운동을 촉진하여 변비 개선에 도움을 주며, 장내 면역력을 향상시키는 것으로 알려져 있다.For this reason, immunity caused by bifidus bacteria is known to be effective in treating atopy, and bifidus bacteria are known to promote intestinal peristalsis to help improve constipation and improve intestinal immunity.
예를 들어, 임상연구를 통해 아토피 소인이 있는 임신부가 비피더스균을 섭취하면 태어날 아기의 아토피 발병률이 절반으로 줄어든다는 연구 결과가 발표되었으며, 산후조리원에서 집단 영아 사망의 원인은 로타바이러스인데, 비피더스균의 섭취가 장염을 앓고 있는 아기의 설사기간, 발열기간, 설사횟수, 구토횟수를 감소시킨다는 임상연구결과 또한 발표되었다.For example, clinical studies have shown that pregnant women with atopy predisposition reduce the incidence of atopy in babies born by birth, and the cause of group infant death in postpartum care centers is rotavirus. Has also been reported to reduce diarrhea, fever, diarrhea and vomiting in babies with enteritis.
이러한 비피더스균은 건강한 인체의 대장에는 충분히 분포되어 있지만, 그렇지 못한 경우에는 상기된 이유에서 유해균이 생성되고 장내 면역력이 저하된다. 특히 나이가 들수록 비피더스 균의 개체수는 급격히 감소하는 것으로 알려져 있다. Such bifidus bacteria are sufficiently distributed in the large intestine of a healthy human body, but otherwise, harmful bacteria are produced and the intestinal immunity is lowered for the reasons mentioned above. In particular, it is known that the population of bifidus bacteria decreases rapidly with age.
즉, 모유를 섭취하는 유아의 경우에는 비피더스가 전체 균 중 90% 이상을 차지한다. 유년기에 접어들면서 점점 줄어드는 비피더스는 노년기에 들면 현저히 줄어든다. 때문에 노인의 장내에 유해세균이나 부패물질이 증가하는 경우가 많고 이로 인해 노인의 체취가 나빠지기도 하므로, 나이가 많을 수록 비피더스 균의 외부공급은 더욱 필요하다.That is, in infants who consume breast milk, bifidus accounts for more than 90% of all bacteria. Bifidus, which decreases gradually as a child, decreases significantly in later life. Because of the increase in the number of harmful bacteria and decay substances in the intestine of the elderly because of this may cause the bad smell of the elderly, the older the need for an external supply of bifidus bacteria.
그런데, 비피더스균은 혐기성 균으로 김치, 치즈와 같은 발효식품을 통해서는 섭취할 수 없다. 요구르트를 통해 섭취할 수 있는 것으로 알려져 있지만, 비피더스균으로 요구르트를 발효시키는 경우 맛이 좋지 않고, 특히 산소에 약한 혐기성균이기 때문에 우유를 발효하기 전에 비피더스균이 사멸하므로, 혐기처리를 위한 과도한 비용으로 생산성이 하락된다.By the way, bifidus bacteria are anaerobic bacteria and can not be consumed through fermented foods such as kimchi and cheese. Although it is known that it can be consumed through yogurt, fermentation of yogurt with Bifidobacterium is not good taste, especially because it is anaerobic which is weak to oxygen, so Bifidobacterium is killed before fermenting milk. Productivity falls.
이러한 상황에서 본 발명과 관련될 수 공지의 종래기술로서, 식이섬유의 섭취를 위한 기능성 식품으로는 예를 들어, 올리고당이 강화된 식이섬유음료(출원 제1019910012951호)나 올리고당 함유 찹쌀식혜의 제조방법(출원 제1019970046591호)가 공지되어 있다.In such a situation, as a related art known in the art, as a functional food for intake of dietary fiber, for example, oligosaccharide-enriched dietary fiber drink (application No. 1019910012951) or oligosaccharide-containing glutinous rice Sikhye (Application No. 1019970046591) is known.
식이섬유의 일기능 중 전기 비피더스균의 활성화를 위한 기능성 식품으로서 음료물을 제공하며, 예를 들어, 상기 올리고당이 강화된 식이섬유음료는 배변을 돕는 식이 섬유와 장내 비피더스균의 영양원으로 사용되는 올리고당을 함유하므로써 생체 기능을 조절하여 건강을 증진시키는 식이 섬유 음료를 제공키 위한 것으로, 덱스트린, 갈락토만난, 구아검을 효소처리하여 얻은 식물성 식이 섬유 4 내지 7%, 대두 올리고당, 갈락토올리고당, 이소말토올리고당 중에서 선택한 올리고당 3 내지 7%를 함유하는 식이 음료 조성물으로 이루어진다.It provides a beverage as a functional food for the activation of electric bifidus bacteria during the work of dietary fiber, for example, the oligosaccharide-enhanced dietary fiber drink is oligosaccharide used as a nutritional source of dietary fiber and bowel bifidus bacteria to help bowel movement It is intended to provide a dietary fiber beverage that improves health by controlling biological functions by containing 4 to 7% of vegetable fiber obtained by enzymatically treating dextrin, galactomannan and guar gum, soybean oligosaccharide, galactooligosaccharide, and isomalto. It consists of a dietary beverage composition containing 3 to 7% of the oligosaccharide selected from oligosaccharides.
이러한 음료물로서의 가공은 대량생산체제가 가능하며, 용이한 섭취가 가능하다는 장점이 있다.Processing as such a beverage has the advantage that it is possible to mass production system, easy intake.
그러나, 이러한 기능성식품은 음료물이라는 단점 역시 내포되어 있다. 이것은 상기된 식이섬유를 함께 섭취하기 위하여 일회복용의 음료용기에 포장됨에 따라, 지속적인 섭취에는 소비자에게 불편함을 뒤따르게 한다.However, these functional foods also have the disadvantage of being a beverage. As this is packaged in a single-use beverage container for ingesting the above-described dietary fiber together, continuous consumption inconvenes the consumer.
즉, 무시될 정도의 무미/무향인 식이섬유 섭취를 위한 기재로서 음료물을 채택함에 따라, 적량의 일회섭취를 위한 개별 음료용기로의 포장, 이를 위한 개별의 구입 및 다량의 비치에 따른 부피와 무게의 증가와 그 저장보관의 불편함과 섭취 후 포장용기의 처리 등 음용에 있어서 상당한 불편함을 끼치게 된다.That is, by adopting a beverage as a substrate for ingesting negligible tasteless and fragrance-free dietary fiber, it is packaged into individual beverage containers for a single ingestion, the volume according to the individual purchase and a large amount of preparation There is considerable inconvenience in drinking such as the increase in weight, the inconvenience of storage and the disposal of packaging containers after ingestion.
따라서, 이러한 기재의 불합리한 채택에 의하여 널리 이용되고 있지 못하고, 오히려 다른 탄산음료와 동일한 취급을 받고 있는 실정인 것이다.Therefore, it is not widely used due to the unreasonable adoption of such a description, but rather is subjected to the same treatment as other carbonated drinks.
또한, 비피더스를 활성화시켜주는 식이섬유의 공급만으로는 절대적으로 부족한 비피더스균의 충분한 개체수를 확보할 수는 없다. 따라서 전기된 바와 같이 외부로부터의 공급이 필요한데, 이러한 비피더스균을 상기 음료수를 통하여 공급하기 어렵다.In addition, the supply of dietary fiber that activates the bifidus alone does not secure a sufficient population of bifidus bacteria that are absolutely insufficient. Therefore, it is necessary to supply from the outside as described above, it is difficult to supply such bifidus through the beverage.
공지된 것으로는 분말형태로 가공된 것이 있지만, 이 역시 기호식품과 조화되지 못한 것이이서, 분말 섭취의 불편함은 사용자에게 부담되어야 하며, 특히 전기된 음료물을 복용하면서 분말의 비피더스균을 섭취하는 것은 더욱 불편한 것이다.Known ones are processed in powder form, but this is also inconsistent with the favorite foods, so the inconvenience of powder intake should be borne by the user, especially ingesting the bifidus of the powder while taking the drink It is more inconvenient.
본 발명과 관련된 또 다른 것으로는, 예를 들어 비피더스가 함유된 청국장 제조방법 및 청국장 가공식품(출원 제1020050127849호)가 공지되어 있다.As another related to the present invention, for example, a method of manufacturing Chunggukjang containing bifidus and Cheonggukjang processed foods (Application No. 1020050127849) are known.
이것은 청국장 제조공정에 의해 제공된 청국장을 건조(동결.열풍.냉풍건조등)시켜 이에 의해 그 대두 자체가 제공하는 섭취크기로서 청국장기재들을 형성하고, 이 청국장기재인 청국장 대두의 외주상에 비피더스를 코팅시키되 늦어도 위에서 상기 청국장기재와 비피더스의 분리를 위해 분말상의 비피더스 입자를 식용 바인더(초콜릿)와 함께 코팅시켜 비피더스 코팅층을 형성하며, 상기 비피더스 코팅층 외주상에 비피더스 코팅층과 외기와의 접촉을 차단함과 동시에 대두로서 청국장 기재의 섭취를 보조하는 식용물질로서 코팅된 음용보조체 코팅층(초콜릿)을 형성시킨 것이다.It dries (freezes, hot air, cold air drying, etc.) provided by the production process of Cheonggukjang, thereby forming the Cheonggukjang materials as the intake size provided by the soybean itself, and coats the bifidus on the outer circumference of the Cheonggukjang soybean. At least at the same time, the powdered bifidus particles are coated together with an edible binder (chocolate) to form a bifidus coating layer to separate the Cheonggukjang substrate and bifidus from above, and at the same time blocking contact between the bifidus coating layer and the outside air on the outer periphery of the bifidus coating layer. As the soybean is to form a beverage auxiliary coating layer (chocolate) coated as an edible substance to aid the intake of the Cheonggukjang substrate.
이를 통해 전기 음료물과는 달리 섭취자의 주변에 항시 비치되기 간편한 초콜릿 형태의 기능성식품으로 제공되며, 그 섭취 또한 용이하게 제공되고 있다.Through this, unlike the electric beverage, it is provided as a functional food in the form of chocolate, which is easy to be always provided around the intake of the intake, and its intake is also easily provided.
그러나, 이러한 기능성 식품은 충분한 생산성을 확보하기 어렵고, 그 구성요소 역시 서로 조합되지 못하고 있다. 즉, 청국장 대두알의 획득을 위하여 전통적인 방법을 취할 수 밖에 없고, 이러한 제조방법은 충분한 생산성을 보장하기 어렵다.However, these functional foods are difficult to secure sufficient productivity, and the components thereof are not combined with each other. In other words, the traditional method for obtaining the soybeans soybeans can not be taken, this manufacturing method is difficult to ensure sufficient productivity.
또한, 상기 초콜릿은 청국장의 혐오취를 은폐 또는 상쇄시키기 위한 것으로, 이를 위해 청국장 낱알당 충분한 양이 제공되어야 하는데, 이러한 기능성식품을 통한 청국장의 충분한 섭취는 초콜릿의 과도한 섭취를 야기할 수 있다.In addition, the chocolate is intended to conceal or offset the hateful odor of Cheonggukjang, for this purpose, a sufficient amount should be provided per grain of Cheonggukjang, sufficient intake of Cheonggukjang through these functional foods may cause excessive consumption of chocolate.
물론, 초콜릿은 그 고유의 약리작용 중에 등의 순기능이 있지만, 그 역기능 역시 무시될 수 없는 것이다.Of course, chocolate has a net function such as during its own pharmacological action, but its reverse function cannot be ignored.
즉, 초콜릿은 의외로 종합영양식품으로 불리우며, 설탕, 유당의 탄수화물, 카카오빈의 전분질, 섬유질, 코코아버터, 유지, 식물성 유지, 카카오 유분의 단백질, 기타 탄닌, 미네랄을 함유하고 있으며, 여성에게 부족되기 쉬운 철도 함유하고 있다.In other words, chocolate is unexpectedly called a comprehensive nutritional product, and contains sugar, lactose carbohydrates, cacao starch, fiber, cocoa butter, fats and oils, vegetable oils, cacao oil protein, other tannins and minerals, and is easy to lack for women. Contains railroads.
또한, 초콜릿에는 사람이 뭔가에 열중하고 있을 때 뇌에서 만들어지는 페닐에칠아민이라는 화학물질이 함유되어 있으며, 코코아버터에는 악성 콜레스테롤을 증식시키지 않는 올레인산, 스테아린산이나, 암, 노화를 방지하는 항산화물질을 함유하고 있다.In addition, chocolate contains a chemical called phenylethylamine, which is made in the brain when a person is immersed in something. Cocoa butter contains oleic acid, stearic acid, which does not increase malignant cholesterol, and antioxidants that prevent cancer and aging. It contains.
그러나, 초콜릿에는 인체에 이로운 성분이 존재하지만 큰 효과를 기대할만한 충분한 양이 존재하는 것은 아니고, 오히려 초콜릿의 과도한 섭취는 여기에 포함된 설탕 등의 과도한 섭취로 비만과 성인병을 불러올 가능성이 있는 것이다.However, there is a beneficial component to the human body in chocolate, but there is not a sufficient amount to expect a great effect, rather, excessive consumption of chocolate is likely to cause obesity and adult diseases by excessive intake of sugar and the like contained therein.
아울러, 청국장에 첨가되는 비피더스는 청국장이 제공하지 못하는 기능을 보완하기 위한 것으로, 청국장에 단순히 나열 배합된 것에 불과한 것으로, 청국장이 비피더스 균을 활성화시키거나 비피더스균이 청국장의 기능을 향상시키기는 어려운 것이어서, 서로 조합된 시너지 효과를 기대하기 어려운 것이다.In addition, the bifidus added to Cheonggukjang is to supplement the functions that Cheonggukjang can not provide, it is simply listed in Cheonggukjang, and it is difficult for Cheonggukjang to activate Bifidus bacteria or Bifidus bacteria to improve the functions of Cheonggukjang. However, it is difficult to expect synergies combined with each other.
결국, 전기된 바와 같이 식품의 주원료 성분들은 저마다 독특한 약리작용을 가지고 있으며 이러한 산재된 식품의 주요소에서 어떠한 것들을 조합시키야 하는가, 그리고 섭취의 용이성 확보를 위해 어떠한 기재를 채택할 것인가가 주요한 관건이라 할 수 있는데, 상술된 종래의 것들로부터는 적절한 기호식품으로서의 제공이 어렵거나, 기호식품으로 제공된다 하더라도, 주요소를 서로 조합 또는 조화시키지 못하며, 충분한 생산성 확보가 어려운 것이다.After all, as mentioned above, the main ingredients of foods have their own unique pharmacological action, and what is important is the combination of the ingredients in these scattered foods, and which descriptions are adopted to ensure ease of consumption. However, from the above-mentioned conventional ones, it is difficult to provide a suitable food as a favorite food, or even if provided as a food of food, it is difficult to combine or harmonize the major ingredients with each other, and to secure sufficient productivity.
이에 본 발명은 상기 문제점을 개선하기 위하여 안출된 것으로서, 식이섬유의 지속적이고 주기적인 섭취를 위하여 분말화된 난소화성 말토덱스트린이 초콜릿에 첨가되며, 또한 이러한 난소화성 말토덱스트린이 장내 비피더스를 활성화시킴에 따라, 상기 기재로서의 초콜릿에 비피더스를 첨가하여 비피더스의 장내 활성화를 더욱 향상시키고, 아울러, 초콜릿에 의해 우려될 수 있는 혈당의 상승 등은 상기 난소화성 말토덱스트린에 의해 조절시켜 그 구성성분이 서로 조화되도록 하며 섭취가 용이한 식이섬유가 함유된 기능성식품 제조방법 및 기능성식품을 제공함에 그 목적이 있는 것이다.Accordingly, the present invention has been made to improve the above problems, powdered indigestible maltodextrin is added to chocolate for continuous and periodic intake of dietary fiber, and also this indigestible maltodextrin activates intestinal bifidus Accordingly, by adding bifidus to the chocolate as the base material, the intestinal activation of bifidus is further improved, and the increase in blood sugar which may be caused by chocolate is controlled by the indigestible maltodextrin so that the components are harmonized with each other. And the purpose is to provide a functional food manufacturing method and functional food containing dietary fiber easy to ingest.
이하, 이 발명이 속하는 기술분야에서 통상의 지식을 갖는 자가 이 발명을 용이하게 실시할 수 있을 정도로 상세히 설명하기 위하여, 이 발명의 가장 바람직한 실시예를 상세히 설명하기로 한다. 이 발명의 목적, 작용효과를 포함하여 기타 다른 목적들, 특징점들이 바람직한 실시예의 설명에 의해 보다 명확해질 것이다.Hereinafter, the most preferred embodiments of the present invention will be described in detail so that those skilled in the art can easily carry out the present invention. Other objects, features, including the effect, the effect of this invention will become more apparent from the description of the preferred embodiment.
참고로 여기에서 개시되는 실시예는 여러가지 실시가능한 예 중에서 당업자의 이해를 돕기 위하여 가장 바람직한 예를 선정하여 제시한 것으로, 이 발명의 기술적 사상이 반드시 이 실시예에 의해서 한정되거나 제한되는 것은 아니고, 본 발명의 기술적 사상을 벗어나지 않는 범위내에서 다양한 변화와 변경이 가능한 것이고, 균등한 타의 실시예가 가능한 것이다.For reference, the embodiments disclosed herein are presented by selecting the most preferred examples to help those skilled in the art from understanding various embodiments, and the technical spirit of the present invention is not necessarily limited or limited by the embodiments. Various changes and modifications can be made without departing from the spirit of the invention, and other equivalent embodiments are possible.
예시도면 도 1 은 본 발명에 따른 식이섬유가 첨가된 기능성식품의 제조방법을 나타낸 개념도로서, 본 발명은 섭취가능한 식이섬유로서 난 소화성 말토덱스트린 분말을 제조하는 식이섬유분말 제조단계와;Exemplary drawings Figure 1 is a conceptual diagram showing a method for producing a dietary fiber added functional food according to the present invention, the present invention comprises a dietary fiber powder manufacturing step of producing an indigestible maltodextrin powder as ingestible dietary fiber;
상기 식이섬유분말 제조와 별도로 섭취를 위한 분말로서 비피더스균 분말 제조단계와;A step of preparing bifidobacteria powder as a powder for intake separate from the preparation of the dietary fiber powder;
상기 식이섬유분말과 상기 비피더스균 분말을 바인딩하면서 상기 획득된 식이섬유 분말과 비피더스 분말을 섭취하기 용이한 기능성식품으로 형성하기 위하여 초콜릿를 매개로 상기 식이섬유분말과 상기 비피더스균 분말을 바인딩시키는 바인딩단계 및 ;A binding step of binding the dietary fiber powder and the bifidus bacteria powder to form the functional food easily ingesting the obtained dietary fiber powder and the bifidus powder while binding the dietary fiber powder and the bifidus powder; and ;
상기 식이섬유분말과 비피더스균 분말이 첨가된 초콜릿을 포장하는 포장단계로 이루어진 식이섬유가 함유된 기능성식품 제조방법이다.It is a functional food manufacturing method containing a dietary fiber consisting of a packaging step of packaging the dietary fiber powder and bifidus powder added chocolate.
여기서, 상기 바인딩단계는 섭취되는 초콜릿의 단당류 분해를 식이섬유에 의해 억제하는 초콜릿 분해 억제물을 첨가시키는 역할을 수행하게 된다.Here, the binding step serves to add a chocolate decomposition inhibitor that inhibits the monosaccharide decomposition of the chocolate ingested by the dietary fiber.
아울러, 바인딩단계에서 식이섬유분말과 비피더스균의 혼합은 섭취된 비피더스균을 증식시키기 위한 비피더스균 활성물질로서 식이섬유를 첨가시키는 역할도 수행하게 된다.In addition, the mixing of the dietary fiber powder and bifidus bacteria in the binding step also serves to add dietary fiber as the bifidus bacteria active material for propagating the ingested bifidus bacteria.
한편, 상기 바인딩단계는 더욱 구체적으로, 초콜릿 페이스트(Paste)에 식이섬유분말을 혼합하여 분말의 군집을 보유지지하기 위한 지지구조물로서 기재를 형성시키고 이 기재표면에 비피더스균 분말을 뿌려 흡착시킨 다음, 비피더스 균이 흡착된 표면상에 초콜릿을 코팅하여 고형화시킨 것을 특징으로 한다.
여기서, 상기 기재는 점착성이 없어서 서로 규합되지 않는 분말상 또는 과립상의 상기 식이섬유분말 또는 비피더스균 분말 군집을 보유지지시키기 위한 지지구조물을 의미한다.On the other hand, the binding step is more specifically, by mixing the dietary fiber powder in the chocolate paste (Paste) to form a substrate as a support structure for holding the population of the powder and sprinkled by adsorbing bifidus powder on the surface of the substrate, It characterized in that the solidified by coating the chocolate on the surface adsorbed bifidus bacteria.
Here, the substrate means a support structure for retaining the powdered or granular powdery or non-Fidder bacteria populations which are not sticky and are not fused together.
그리고, 상기 기재는 상기 초콜릿에 의해 혼합된 식이섬유분말과 비피더스균의 하루 권장량의 섭취를 위해 낱알로서 형성됨이 바람직하다.And, the base material is preferably formed as a grain for the intake of the recommended daily dietary fiber powder and bifidus bacteria mixed by the chocolate.
또한, 상기 기재 표면으로의 초콜릿 코팅은 탈지처리된 초콜릿으로 코팅되어 쉘락 또는 폴리싱처리된 것을 특징으로 한다.In addition, the chocolate coating on the surface of the substrate is characterized by being coated with degreasing chocolate and shellaced or polished.
이러한 제조방법에 의해 제조된 식이섬유가 함유된 기능성 식품이 제공되며, 본 발명의 식이섬유가 첨가된 기능성식품은 특히 섭취가능한 식이섬유분말과 섭취된 식이섬유에 의해 활성화되는 비피더스균을 제공하기 위한 비피더스균 분말과 상기 식이섬유분말과 비피더스균을 함께 섭취하기 위한 기재로서 식이섬유분말과 비피더스균이 혼합되어 섭취가능하게 고형으로 성형되며, 상기 식이섬유에 의해 단당류의 섭취가 억제되는 초콜릿으로 이루어진 것을 특징으로 한다.Provided is a functional food containing a dietary fiber prepared by such a manufacturing method, the functional food to which the dietary fiber of the present invention is added, particularly to provide an ingestible dietary fiber powder and bifidus bacteria activated by the ingested dietary fiber. As a substrate for ingesting the bifidus powder, the dietary fiber powder and the bifidus bacteria together, the dietary fiber powder and the bifidus bacteria are mixed to be ingested in a solid form, and the dietary fiber is made of a chocolate in which the intake of monosaccharides is suppressed. It features.
이때, 상기 식이섬유분말은 총중량에 대해 6중량% 내지 30중량%로 첨가된 것을 특징으로 한다.At this time, the dietary fiber powder is characterized in that added to 6% by weight to 30% by weight based on the total weight.
한편, 상기 비피더스균분말은 총중량에 대해 0.5중량% 내지 3중량%로 첨가된 것을 특징으로 한다.On the other hand, the bifidus powder is characterized in that added to 0.5% to 3% by weight based on the total weight.
상술된 바와 같이 본 발명은 인체에 유익한 식이섬유 분말과 비피더스균 분말이 비치가 간편하고 그 풍미감과 맛에 의해 섭취가 용이하게 초콜릿에 함유되어 간식이나 기호식품으로서 섭취가 수행되도록 하고, 또한 상기 식이섬유에 의해 초 콜릿 섭취의 단점을 개선한 식이섬유가 함유된 기능성식품 제조방법 및 이에 의해 제조된 기능성식품을 제공한다.As described above, the present invention provides the dietary fiber powder and the bifidus fungus powder, which are beneficial to the human body, are easily contained and easily ingested in chocolate by its flavor and taste, so that the ingestion is performed as a snack or a favorite food, and the dietary Provided is a functional food manufacturing method containing a dietary fiber that improves the disadvantages of ultra-collet intake by the fiber and the functional food produced thereby.
이를 위한 본 발명은 크게 식이섬유 분말제조단계와 비피더스균 분말제조단계 및 이들의 바인딩 단계와 포장단계로 크게 구분된다.The present invention for this purpose is largely divided into dietary fiber powder production step and bifidus bacteria production step and their binding step and packaging step.
상기 식이섬유는 전기된 바와 같이, 식이섬유는 비영양성 다당류로서 소화효소로 소화되지 않는 물질이나, 글리세믹스인덱스(GI)에 관계되어 심혈관계 질환의 예방과 치료에 도움을 줄 뿐 아니라 당뇨병, 비만해소, 변비완화 및 소화관 기능개선등, 만성질환의 예방과 처치에 있어서 식이요법으로서 중요하게 부각되고 있다.As described above, the dietary fiber is a non-nutritive polysaccharide, which is not digested with digestive enzymes, but is related to glycemic index (GI) to help prevent and treat cardiovascular diseases as well as diabetes and obesity. It is important as a dietary therapy in the prevention and treatment of chronic diseases such as relieving, reducing constipation and improving digestive tract function.
한편, 상기 식이섬유의 또 다른 기능으로는 장내환경을 개선하는 비피더스균의 활성화에 있으며, 전기된 바와 같이, 비피더스균은 이것이 생산하는 항생물과 유기산이 유해균을 억제시켜 독소를 생성하고 설사를 유발하는 유해균을 억제시키는 작용을 수행한다.On the other hand, another function of the dietary fiber is the activation of bifidobacteria, which improves the intestinal environment. As described above, bifidobacteria inhibits harmful bacteria from the antibiotics and organic acids that it produces toxins and induces diarrhea. It acts to suppress harmful bacteria.
이러한 식이섬유와 비피더스균이 함께 조합될 때, 장내의 환경은 크게 개선되며, 미량의 비피더스균의 첨가로도 상기 식이섬유에 의해 적극적으로 증식될 수 있다.When these dietary fibers and bifidus bacteria are combined together, the intestinal environment is greatly improved, and even with the addition of trace amounts of bifidus bacteria, they can be actively propagated by the dietary fibers.
상기 식이섬유와 비피더스균은 섭취하기 용이한 형태로서 분말로서 제조된다. 그리고 무시될 정도로 무미와 무향인 식이섬유 분말과 비피더스균 분말을 섭취가 용이한 형태로 공급하기 위하여 맛과 향을 첨가하는 바인딩 기재로서 초콜릿과 혼합된다.The dietary fiber and bifidus bacteria are prepared as a powder in an easy form to ingest. And it is mixed with chocolate as a binding base to add taste and aroma in order to supply negligible tasteless and fragrance-free dietary fiber powder and bifidus bacteria powder in an easy-to-eat form.
그리고 이때, 식이섬유는 전기된 바와 같이 GI를 감소시키는 그 특유의 기능 에 따라, 초콜릿이 함유하는 탄수화물과 설탕의 체내흡수를 방해하여 초콜릿에 의한 역기능을 개선시킨다.At this time, the dietary fiber, according to its unique function of reducing GI, as described above, interferes with the body absorption of carbohydrate and sugar contained in chocolate to improve the dysfunction caused by chocolate.
좀 더 구체적으로 상기 식이섬유 분말제조단계는 예를 들어 전분(감자)에 희석한 명산을 소정량(500~1000ppm) 산포하고 균일하게 혼합한 다음, 건조기를 사용하여 수분함유량 3% 정도로 예비건조를 수행한다.More specifically, the dietary fiber powder manufacturing step may be, for example, disperse a predetermined amount (500-1000 ppm) of the dilute acid diluted in starch (potato) and mix it uniformly, and then pre-dry it to a moisture content of about 3% using a dryer. Perform.
이때, 일반적으로 난소화성성분의 함유량은 가열시간과 비례되므로, 150~200℃ 에서 일정의 난소화성분을 함유할 때까지 가열을 수행한다.At this time, since the content of the indigestible component is generally proportional to the heating time, heating is performed at 150 to 200 ° C. until it contains a predetermined indigestible component.
여기서 획득된 중간생성물을 물에 용해하여 pH를 조정한 다음, 정제공정의 용이성을 위해 점도조정을 수행한다. 점도조정은 α-아밀라제에 따라 가수분해를 통해 수행한다.The intermediate product obtained here is dissolved in water to adjust pH, and then viscosity adjustment is performed for ease of purification process. Viscosity adjustment is carried out via hydrolysis according to α-amylase.
다음으로, 활성탄을 첨가하여 탈색 여과후, 이온교환수지에 따라 탈염, 탈색, 탈취를 수행한다. 그리고 농축하여 스프레이 건조를 통해 식이섬유로서 난 소화성 말토덱스트린 분말을 획득한다.Next, the activated carbon is added, followed by decolorization filtration, followed by desalting, decolorization, and deodorization depending on the ion exchange resin. And concentrated to obtain a fire-extinguishing maltodextrin powder as a dietary fiber through spray drying.
한편, 이러한 식이섬유 분말과 별도로 비피더스균 분말제조단계를 수행한다.비피더스균 분말은 혐기배양 시스템에 의해 동결건조된 분말(또는 과립)형태로 생성되며, 이것은 전기된 바와 같이 비피더스균이 산소에 약하고, 초산생산에 의해 적당한 맛과 풍미를 기대하기 어렵기 때문이다.On the other hand, the bifidobacteria powder manufacturing step is performed separately from the dietary fiber powder. Bifidus bacteria powder is produced in the form of lyophilized powder (or granules) by an anaerobic culture system, which, as described above, is susceptible to oxygen It is because it is difficult to expect proper taste and flavor by acetic acid production.
위산과 담즙산에 대한 저항성을 향상시킨 장도달율을 향상시킴과 더불어 장정착능력을 개선시킨 비피더스균 가공식품(동결건조분말)은 이미 일반적인 것이며 공연실시되어 있으므로, 상세한 설명은 생략한다.Bifidobacteria processed foods (freeze-dried powders), which have improved intestinal delivery and improved intestinal sequestration, are already common and have been performed, and thus detailed descriptions are omitted.
다음으로, 바인딩단계는 상기 획득된 식이섬유 분말과 비피더스 분말을 섭취하기 용이한 기능성식품으로서 기호식품 가공단계이다. 상기 기호식품으로서의 초콜릿은 첫째, 식이섬유 분말과 비피더스 분말을 바인딩시키는 기재, 즉 분말의 군집을 보유지지하기 위한 지지구조물이며, 이를 통해 하루 권장량의 식이섬유 분말과 비피더스 분말을 고형화된 초콜릿으로서 제공할 수 있다.Next, the binding step is a preference food processing step as a functional food easy to ingest the obtained dietary fiber powder and bifidus powder. The chocolate as a favorite food is, firstly, a support structure for retaining a substrate binding the dietary fiber powder and the bifidus powder, that is, a cluster of powders, thereby providing a daily recommended amount of the dietary fiber powder and bifidus powder as the solidified chocolate. Can be.
이를 위한 초콜릿은 낱알로서 분리되고 하나의 포장용기에 군집되어 제공되며, 그 성형이 자유롭고 음료수와는 실온에서 보관이 용이하고 장기의 유통기한이 확보될 수 있기 때문이다.This is because the chocolate is separated into grains and provided in a packed container, the molding is free, and the beverage can be easily stored at room temperature and a long shelf life can be secured.
여기에, 상기 식이섬유는 실험적으로 하루 권장량의 최소량은 기준될 수 있으나, RDI(하루 섭취 허용량)은 제한이 되지 않은 것으로 WHO의 안정성 평가에서는 A1으로 분류되어 있다. Here, the dietary fiber can be experimentally based on the minimum amount of the recommended daily dose, but RDI (day intake allowance) is not limited and is classified as A1 in the stability evaluation of WHO.
이러한 하루 섭취 허용량이 제한되어 있지 않음에 따라 상기 식이섬유의 충분한 섭취는 초콜릿의 과다섭취를 야기시킬 수 있으나, 이때 상기 혼합되는 식이섬유는 초콜릿에 의해 제공되는 당류의 체내 흡수를 방해하게 된다.As such daily intake is not limited, sufficient intake of dietary fiber may cause excessive ingestion of chocolate, but the mixed fiber may interfere with the body's absorption of the sugars provided by the chocolate.
따라서, 상기 바인딩단계에서 식이섬유분말을 바인딩 하기 위한 초콜릿과의 혼합, 역으로 초콜릿으로의 식이섬유 분말 첨가는 섭취되는 초콜릿의 단당류 분해를 식이섬유에 의해 억제하는 초콜릿 분해 억제물 첨가단계인 것이다.Therefore, the mixing with the chocolate to bind the dietary fiber powder in the binding step, conversely, the addition of dietary fiber powder to chocolate is a chocolate decomposition inhibitor addition step of inhibiting the monosaccharide decomposition of the ingested chocolate by the dietary fiber.
구체적으로 초콜릿 기재는 유기농 설탕과 코코아버터, 식물성유지, 전지분유가 혼합되어 이루어지며, 코코아버터가 포함된 페이스트(Paste) 상태의 초콜릿은 점성이 높으며, 이것은 비피더스균 분말을 흡착시키기에 충분한 물성을 지니고 있 다.Specifically, the chocolate base is made of a mixture of organic sugar, cocoa butter, vegetable oil, and whole milk powder, and the chocolate in the paste state containing cocoa butter has a high viscosity, which is sufficient to adsorb bifidus powder. It has it.
이에 따라, 상기된 바와 같이 낱알 형태의 1차기재로서 식이섬유와 초콜릿을 혼합하여 초콜릿 기재를 형성시키고, 이 초콜릿 기재 표면에 비피더스균 분말을 뿌려 낱알기재 위에 비피더스균을 흡착시킨다.Accordingly, as described above, the dietary fiber and the chocolate are mixed to form a chocolate substrate as the first base material in the form of grains, and the bifidus bacteria are sprinkled on the surface of the chocolate base material to adsorb the bifidus bacteria.
다음으로, 여기에 다시 마감재로서 초콜릿을 다시 코팅하고 쉘락 또는 폴리싱 처리를 통해 외부를 마감시키며, 이것은 초콜릿 낱알 외부로 식이섬유분말과 비피더스균 분말이 노출되고 이에 의해 마찰에 의한 분말의 기재이탈 등을 방지시키기 위함이다.Next, the chocolate is again coated as a finishing material and the outside is finished by shellac or polishing, which exposes the dietary fiber powder and the bifidus powder to the outside of the chocolate grain, thereby removing the substrate from the powder by friction. To prevent this.
이때, 상기 마감재로서 코팅되는 초콜릿은 내열처리된 초콜릿이 사용될 수 있다. 내열처리 초콜릿은 탈지방 또는 저지방 초콜릿을 의미한다. In this case, the chocolate coated as the finishing material may be a heat-treated chocolate. Heat-resistant chocolate refers to defatted or low fat chocolate.
상기 초콜릿의 온도 취약성은 초콜릿에 함유되는 지방에 특히 기인되는데, 초콜릿은 그 구조적 특성 중에서도 결정도(Crystallinity)는 그 함유 지방에 의해서 좌우되며, 함유지방이 높을수록 온도 상승에 따라 결정도가 상실되어 쉽게 용융되는 성질이 있기 때문이다.The temperature fragility of the chocolate is due to the fat contained in the chocolate, the chocolate crystallinity of the structural properties (Crystallinity) is dependent on the content of the fat contained, the higher the fat content, the more the crystallinity is lost as the temperature rises easily This is because it has a property of melting.
상기 초콜릿은 그 유지성분으로 유지방이 첨가되어 제조되며, 이것은 초콜릿의 맛을 더욱 향상시키고, 부드러운 맛을 발휘시키기 위함이다.The chocolate is prepared by adding milk fat as its fat or oil component, which is to further improve the taste of the chocolate and to exhibit a soft taste.
그런데, 초콜릿은 그 물류과정에서 특히 온도에 취약성을 야기시키며, 특히 낱알로 분리되고 이것이 포장용기에 군집되어 포장될 때 더욱 그러하다.By the way, chocolate is particularly vulnerable to temperature in the distribution process, especially when it is separated into grains and packed in packed containers.
예를 들어, 기온이 높은 여름철에 초콜릿이 녹게 되면, 녹아 유출된 초콜릿이 서로 들러붙게 되어, 낱알 상태로 보유되어야 하는 보관상태가 손상되므로 상품 성이 저하되는 것이다.For example, when the chocolate melts in the summer when the temperature is high, melted and spilled chocolate sticks to each other, which impairs the storage state that must be retained in a grain state, thereby degrading the commerciality.
이를 방지하기 위하여 냉장 수송과 냉장진열은 제품의 물류상 바람직하지 못하게 되며, 상기 마감재로서 코팅되는 초콜릿은 그 지방의 함유량을 감소시켜 내열성을 향상시킴이 바람직한 것이다.In order to prevent this, refrigerated transportation and refrigerated display are not desirable in terms of logistics of the product, and the chocolate coated as the finishing material is preferable to improve the heat resistance by reducing the content of fat.
이러한 본 발명에 의해 제조된 기능성식품으로서의 초콜릿은 그 총중량에 대하여 식이섬유분말이 6중량% 내지 30중량%를 함유하게 형성시킴이 바람직하며, 한편, 비피더스분말은 상기 식이섬유에 의해 활성화되므로, 극히 미량만이 첨가되어도 충분하다. The chocolate as the functional food prepared by the present invention is preferably formed so that the dietary fiber powder contains 6% to 30% by weight based on the total weight thereof. On the other hand, the bifidus powder is activated by the dietary fiber. Only a small amount is added.
비피더스균 분말은 총중량에 대하여 0.5중량% 내지 3중량% 만이 첨가되는 것으로도 상기 식이섬유에 의한 충분한 증식이 기대된다.Bifidobacteria powder is expected to be sufficiently multiplied by the dietary fiber even if only 0.5 to 3% by weight based on the total weight is added.
상술된 바와 같이 본 발명에 따르면, 첫째 식이섬유와 비피더스가 기호식품인 초콜릿과 조화되어 기능성식품으로 제공되므로, 섭취자 주변으로 그 비치가 간편하고 섭취가 용이하다는 효과가 있다.As described above, according to the present invention, since the first dietary fiber and bifidus are provided as a functional food in harmony with chocolate, which is a favorite food, there is an effect that the preparation is simple and easy to consume around the intake.
둘째, 이때 상기 식이섬유와 비피더스가 함께 제공됨으로, 소량의 비피더스 제공으로도 식이섬유에 의해 활성화되는 효과가 있다.Second, since the dietary fiber and bifidus are provided together, there is an effect of being activated by the dietary fiber even with a small amount of bifidus.
셋째, 상기 식이섬유는 그 충분한 섭취에 따르는 초콜릿의 섭취에서 당류의 체내흡수를 방해하여 초콜릿의 과다섭취에 의한 폐해가 방지되므로, 초콜릿이 식이섬유와 비피더스를 제공하기 위한 기재로 사용되어도 무리가 없다는 효과가 있다.Third, since the dietary fiber prevents the ingestion of saccharides in the intake of chocolate according to the sufficient intake of the chocolate to prevent the damage caused by excessive intake of chocolate, even if chocolate is used as a substrate for providing dietary fiber and bifidus It works.
넷째, 상기 식이섬유분말의 제조와 비피더스 분말의 제조와 초콜릿의 제조는 서로 독립적인 것이고, 제조된 요소들의 바인딩단계가 간편한 것이어서, 대량생산이 가능하고, 충분한 생산성이 확보되는 효과가 있다.Fourth, the production of the dietary fiber powder and the production of bifidus powder and the production of chocolate are independent of each other, and the binding step of the manufactured elements is simple, mass production is possible, and sufficient productivity is secured.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070053866A KR100877189B1 (en) | 2007-06-01 | 2007-06-01 | Process for Making Functional Foods Containing Dietary Fiber and Functional Foods Thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070053866A KR100877189B1 (en) | 2007-06-01 | 2007-06-01 | Process for Making Functional Foods Containing Dietary Fiber and Functional Foods Thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20080105811A KR20080105811A (en) | 2008-12-04 |
KR100877189B1 true KR100877189B1 (en) | 2009-01-07 |
Family
ID=40367037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070053866A KR100877189B1 (en) | 2007-06-01 | 2007-06-01 | Process for Making Functional Foods Containing Dietary Fiber and Functional Foods Thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100877189B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5455235A (en) * | 1992-04-10 | 1995-10-03 | Otsuka Pharmaceutical Co., Ltd. | Food composition for inhibiting the formation of an intestinal putrefactive product |
KR20050019338A (en) * | 2003-08-18 | 2005-03-03 | 정명준 | Method for manufacturing dosage form containing the lactobacillus powder and novel use of thr lactobacillus |
KR100685380B1 (en) * | 2005-12-22 | 2007-02-22 | 장익순 | Manufacturing method of chung-guk-jang including bifidus and processed food of chung-guk-jang including bifidus |
-
2007
- 2007-06-01 KR KR1020070053866A patent/KR100877189B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5455235A (en) * | 1992-04-10 | 1995-10-03 | Otsuka Pharmaceutical Co., Ltd. | Food composition for inhibiting the formation of an intestinal putrefactive product |
KR20050019338A (en) * | 2003-08-18 | 2005-03-03 | 정명준 | Method for manufacturing dosage form containing the lactobacillus powder and novel use of thr lactobacillus |
KR100685380B1 (en) * | 2005-12-22 | 2007-02-22 | 장익순 | Manufacturing method of chung-guk-jang including bifidus and processed food of chung-guk-jang including bifidus |
Also Published As
Publication number | Publication date |
---|---|
KR20080105811A (en) | 2008-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sawale et al. | Isomaltulose (palatinose)–an emerging carbohydrate | |
CN102687750B (en) | Weight losing and meal replacement protein type solid beverage | |
US6248390B1 (en) | Fiber-water—water containing soluble fiber | |
CN101933568B (en) | Low-heat nutrient heal-care sugar and production method thereof | |
CN100536684C (en) | Mixed grain soybean milk | |
CN104287049A (en) | Meal replacement protein powder solid beverage for managing body weight | |
BG107094A (en) | Carbohydrate system and a method for providing nutrition to a diabetic | |
CN105360891A (en) | Flour having low glycemic index and making method thereof | |
CN104720063A (en) | Konjac dietary fiber solid drink and packaging and drinking methods thereof | |
JP2013513368A (en) | Nutritional products containing hydrolyzed whole grains | |
CN106690331A (en) | Kelp dietary fiber granules and preparation method thereof | |
CN101176553A (en) | Fresh fruit konjak functional food and preparation method thereof | |
Sentko et al. | Isomaltulose | |
CN108208741B (en) | Functional edible salt, low-sodium salt and salty seasoning and preparation method thereof | |
CN112136894A (en) | Nutritional dietary supplement food beneficial to cardiovascular health and preparation method and application thereof | |
KR100614056B1 (en) | Functional dietary fiber supplement for the improvement of intestinal health and manufacturing method thereof | |
CN106360463A (en) | Sugar-free, high-fiber and high-protein siraitia grosvenorii convenient food and preparation method thereof | |
CN113475716A (en) | Supplementary diet for losing weight and preparation method and application thereof | |
KR100877189B1 (en) | Process for Making Functional Foods Containing Dietary Fiber and Functional Foods Thereof | |
CN108523123A (en) | A kind of full nutritional support food of diabetes | |
CN104413238A (en) | Preserved clausena lansium throat sugar | |
US20150189901A1 (en) | Resistant Starch Food Bar System | |
JP2000189109A (en) | Liquid food | |
KR20060024766A (en) | Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood | |
JP2005013197A (en) | Juice having pre-biotics effect, capable of being drunk before, in and after meal, and promoting appetite, digestion and absorption of food and enhancing function of excretion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121217 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140107 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20141022 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20160120 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170912 Year of fee payment: 9 |
|
R401 | Registration of restoration | ||
FPAY | Annual fee payment |
Payment date: 20170920 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190121 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20200106 Year of fee payment: 12 |